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OBJECTIVE — Toinvestigatethelong-termassociationsofmagnesiumintakewithincidence
of diabetes, systemic inﬂammation, and insulin resistance among young American adults.
RESEARCH DESIGN AND METHODS — A total of 4,497 Americans, aged 18–30
years, who had no diabetes at baseline, were prospectively examined for incident diabetes based
on quintiles of magnesium intake. We also investigated the associations between magnesium
intake and inﬂammatory markers, i.e., high-sensitivity C-reactive protein (hs-CRP), interleu-
kin-6 (IL-6), and ﬁbrinogen, and the homeostasis model assessment of insulin resistance
(HOMA-IR).
RESULTS — During the 20-year follow-up, 330 incident cases of diabetes were identiﬁed.
Magnesium intake was inversely associated with incidence of diabetes after adjustment for
potentialconfounders.Themultivariable-adjustedhazardratioofdiabetesforparticipantsinthe
highest quintile of magnesium intake was 0.53 (95% CI, 0.32–0.86; Ptrend  0.01) compared
with those in the lowest quintile. Consistently, magnesium intake was signiﬁcantly inversely
associated with hs-CRP, IL-6, ﬁbrinogen, and HOMA-IR, and serum magnesium levels were
inversely correlated with hs-CRP and HOMA-IR.
CONCLUSIONS — Magnesium intake was inversely longitudinally associated with inci-
dence of diabetes in young American adults. This inverse association may be explained, at least
in part, by the inverse correlations of magnesium intake with systemic inﬂammation and insulin
resistance.
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A
lthoughobesityisanimportantrisk
factor for diabetes, certain foods or
nutrients may also be associated
with an increased risk of diabetes (1).
Magnesium, found in whole grains, is an
essential cofactor for multiple enzymes
involved in glucose metabolism (2). Sev-
eralcohortstudieshaveinvestigatedmag-
nesium intake in relation to risk of
diabetes, but the ﬁndings have been in-
consistent (3). Some (4–6), but not all
(7–9), studies found an inverse associa-
tion between magnesium intake and dia-
betes risk. Of note, all previous studies
except one (7) used self-reported cases,
and all studies were conducted among
middle-aged or elderly individuals.
In addition, the pathophysiological
mechanisms underlying the beneﬁcial ef-
fects of magnesium intake on diabetes are
not fully understood. Cross-sectional
studieshavesuggestedaninversecorrela-
tion between magnesium intake and in-
ﬂammatory markers (10,11), and some
clinical and experimental studies have
suggested that magnesium may improve
insulin sensitivity (12,13). Therefore, we
investigatedmagnesiumintakeinrelation
to the incidence of diabetes in a large
cohort of young American adults partici-
pating in the Coronary Artery Risk Devel-
opment in Young Adults (CARDIA)
study. To explore possible mechanisms,
wealsoexaminedwhethermagnesiumin-
take is inversely associated with systemic
inﬂammation markers, i.e., high-
sensitivity C-reactive protein (hs-CRP),
interleukin-6 (IL-6), and ﬁbrinogen, and
withthehomeostasismodelassessmentof
insulin resistance (HOMA-IR).
RESEARCH DESIGN AND
METHODS— The CARDIA study is
an ongoing, multicenter, prospective co-
hort study investigating the role of life-
styleandotherfactorsinthedevelopment
of risk factors for cardiovascular diseases
among young adults (14). In brief, 5,115
AfricanAmericanandCaucasianmenand
women, aged 18–30 years, were enrolled
from1985to1986.Todate,sixfollow-up
examinations have been completed. The
average follow-up rate was 94.1%, and
70% of participants in the original co-
hort completed the follow-up examina-
tion at year 20 (2005–2006).
For analyses, we excluded partici-
pants who had taken antidiabetes medi-
cations and/or had a fasting plasma
glucose 7 mmol/l at baseline (n  35),
those who did not participate in any fol-
low-up examinations (n  204), those
who had missing data on magnesium or
total energy intake or who reported im-
plausible total energy intake (800 or
8,000 kcal/day for men or 600 or
6,000 kcal/day for women, n  74),
and women who were pregnant at any
examination (n  233). We further ex-
cludedparticipantswhohadmissingdata
on smoking status (n  33), alcohol con-
sumption (n  18), physical activity (n 
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(n  6). After these exclusions, a total of
4,497 participants (87.9% of 5,115) re-
mained in the analyses.
All participants gave written in-
formed consent. The study design, data
collection, and analyses were approved
by the institutional review boards of the
centers involved.
Assessment of magnesium intake
and other dietary factors
The details of dietary assessment and val-
idation of magnesium intake in CARDIA
have been described previously (15). In
brief, we collected dietary data, including
magnesium intake at baseline and exam-
ination years 7 and 20, using a validated
interviewer-administered CARDIA Diet
History Questionnaire (16). Information
on supplement use was also collected.
Magnesiumintakerepresentedthesumof
dietary magnesium intake and magne-
sium supplement.
Measurement of other covariates
Age, sex, ethnicity, years of education,
smokingstatus,andalcoholconsumption
were self-reported, obtained by interview
or self-administered questionnaire.
Smoking status was classiﬁed as never,
former, and current. Alcohol consump-
tion was classiﬁed into four groups based
on daily amount ingested: none, 0.1–9.9,
10–19.9, and 20 g/day. BMI was calcu-
lated as weight in kilograms divided by
the square of height in meters and was
classiﬁed into three groups: 25, 25–
29.9,and30kg/m
2(17).Waistcircum-
ference was measured at the maximum
abdominal girth, and all anthropometric
measures were taken in duplicate and av-
eraged. Three measurements of resting
systolic and diastolic ﬁfth-phase blood
pressures were taken using a random-
zero sphygmomanometer. The average of
the second and third measurements was
used in the analyses. Physical activity was
assessed using the interview-based, vali-
dated, CARDIA Physical Activity History
Questionnaire (18). A score of 100 exer-
cise units is approximately equivalent to
participation in vigorous activity for 2–3
h/weekduring6monthsoftheyear.Fam-
ily history of diabetes was deﬁned as ei-
ther mother or father having diabetes.
Assessment of inﬂammatory
markers, HOMA-IR, oral glucose
tolerance test, and A1C
Serum hs-CRP was measured at years 7,
15, and 20, with a nephelometry-based
highthroughputassay.Intra-andinteras-
say coefﬁcients of variations (CVs) were
2.3–4.4 and 2.1–5.7%, respectively. IL-6
was analyzed at year 20 using a high-
sensitivity enzyme-linked immunosor-
bent assay. A routine CV was 6.3%.
Fibrinogen was assessed at years 5, 7, and
20 by the Clauss method (year 5) and a
BNII nephelometer (years 7 and 20) cali-
bratedwithstandardnormalplasma(19).
Intra- and interassay CVs were 2.7 and
2.6% at year 7 and 3.1 and 4.2% at year
20. Fasting plasma glucose and insulin
levelsweredeterminedbythehexokinase
ultraviolet method and radioimmunoas-
say,respectively,atyears0,7,10,15,and
20. Masked analysis of split serum sam-
ples resulted in a technical error of 16.6%
for mean insulin levels (r  0.98). Be-
tween-method correlation was 0.83.
HOMA-IR was calculated as glucose (mil-
limoles per liter)  insulin (milliunits per
liter)/22.5 (20).
Two-hour plasma glucose levels were
measured from a standard 2-h oral glu-
cose tolerance test (OGTT) at years 10
and 20. A1C was assessed using a Tosoh
G7 high-performance liquid chromatog-
raphy instrument at year 20. The interas-
say CVs were 2.0–3.0%.
Ascertainment of diabetes
Participants with one or more of the fol-
lowing were determined to have diabetes:
1) fasting plasma glucose 7.0 mmol/l
(years 0, 7, 10, 15, and 20); 2) nonfasting
plasmaglucose11.1mmol/l(years0,7,
10, 15, and 20); 3) postprandial 2-h
plasma glucose 11.1 mmol/l from an
OGTT (years 10 and 20); 4) A1C 6.5%;
(year 20); or 5) reported use of antidiabe-
tes medications (all examinations), which
were veriﬁed by medication names (21).
We could not clearly distinguish diabetes
type, because some participants were
young at diagnosis and used insulin as
treatment. Therefore, we used the term
“diabetes” rather than “type 2 diabetes,”
but the great majority of participants had
type 2 diabetes.
Statistical analysis
Participants were divided into quintiles
according to magnesium intake (milli-
grams/1,000 kcal). Baseline characteris-
tics of participants were calculated as
mean and SD, median and interquartile
range, or percentage and were compared
according to quintiles of magnesium in-
take using ANOVA, a Kruskal-Wallis test,
or a 
2 test as appropriate.
We used the Cox proportional haz-
ards model to estimate the hazard ratios
(HRs)and95%CIsofincidentdiabetes.
Follow-up time was calculated as the
difference between the baseline exami-
nation and the year in which diabetes
was ﬁrst identiﬁed, year 20, or the year
a participant was censored. To best rep-
resent long-term dietary intake and to
minimize measurement error and the
effect of diagnosed diabetes or other
conditions on diet, we used only base-
line magnesium intake in relation to
cases identiﬁed at years 2, 5, and 7 and
used the average magnesium intake of
baseline and year 7 in relation to cases
occurringatyears10,15,and20(15).If
year 7 data were missing, we imputed
by multiplying baseline magnesium in-
take and the ratio of the mean values at
two examinations. In addition, because
the cutoff point of fasting glucose for
deﬁningdiabeteswaschangedfrom140
to 126 mg/dl in 1997, we used a cutoff
point of 140 mg/dl at years 0, 7, and 10
in sensitivity analysis to test the robust-
ness of our results.
The initial analysis (model 1) was ad-
justed for age, sex, ethnicity, and study
center. In model 2, we further adjusted
for education, smoking status, alcohol
consumption, physical activity, family
history of diabetes, BMI, systolic blood
pressure, and total energy intake. In
model 3, we additionally adjusted for di-
etary intake of saturated fat and crude ﬁ-
ber. Continuous variables using the
median value in each quintile were cre-
ated for trend tests.
In addition, we tested for possible in-
teractions between magnesium intake
and sex, ethnicity, family history of dia-
betes, and BMI by adding corresponding
multiplicative interaction terms in the
models, followed by the likelihood ratio
test. We also stratiﬁed the data according
to these variables to determine whether
they modiﬁed the associations.
We examined the association be-
tween magnesium intake and serum
levels of inﬂammatory markers and
HOMA-IR. A logarithmic transforma-
tion was used to improve the normality
of hs-CRP, IL-6, ﬁbrinogen, and
HOMA-IR distributions. Because hs-
CRP, ﬁbrinogen, and HOMA-IR were
measured multiple times, generalized
estimatingequationswithexchangeable
correlation structure for simplicity were
used. Analogous to the accumulative
diet method used in the Cox models,
we used the average magnesium intake
of years 0 and 7 for all repeated mea-
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20. Because IL-6 was measured once,
the general linear model was used. The
adjusted covariates in the models were
the same as those listed in Table 3.
We examined the correlation be-
tween serum and magnesium intake at
year 20 and also analyzed the relations
between serum magnesium and inﬂam-
matory markers and HOMA-IR using the
general linear model, after adjustment for
covariates in the same year in the manner
described above.
AllanalyseswereperformedwithSAS
(version 9.1.3; SAS Institute, Cary, NC).
P  0.05 was considered statistically
signiﬁcant.
RESULTS— Baseline characteristics
of4,497participantsaccordingtoquin-
tiles of magnesium intake are shown in
Table 1. Compared with participants
in the lowest quintile of magnesium in-
take, those in the highest quintile were
slightly older and more likely to be fe-
male, Caucasian, and not current smok-
ers. They also had lower BMI and waist
circumference and were less likely to
have a family history of diabetes. In ad-
dition, they had higher rates of magne-
sium supplement use and crude ﬁber
intake and lower intakes of total energy
and saturated fat. The correlation coef-
ﬁcients of total magnesium intake with
magnesium supplementation and
whole grain consumption were 0.58
and 0.25 at year 0 and 0.71 and 0.25 at
year 7 (all P  0.001).
Duringthe20-yearfollow-up,330in-
cident cases of diabetes were identiﬁed,
including 212 cases determined by fast-
ing glucose criteria and 3, 37, 35, and 43
cases determined by nonfasting glucose,
2-h glucose after OGTT, A1C, and an-
tidiabetes medication use criteria, respec-
tively. Magnesium intake was inversely
associatedwithincidenceofdiabetes.The
incidence of diabetes was 47% lower (HR
0.53 [95% CI 0.32–0.86]; Ptrend  0.01)
for participants in the highest quintile
comparedwiththatforthoseinthelowest
quintile, after adjustment for age, sex,
ethnicity, study center, and other poten-
tial confounders (Table 2). When data
were stratiﬁed according to magnesium
supplementation, the observed inverse
associationsweregenerallyconsistentbut
were somewhat attenuated among sup-
plement nonusers because the range of
magnesium intake was substantially nar-
rowed (Table 2).
When we substituted waist circum-
ference for BMI in model 3, a similar in-
verse association was observed (HR 0.59
[95% CI 0.36–0.98]; Ptrend  0.04). In
addition, when we used different deﬁni-
tions of diabetes based on the time period
oftheexamination,atotalof327incident
cases of diabetes were identiﬁed. These
Table 1—Baseline characteristics of CARDIA study participants according to total magnesium intake quintiles
Characteristics Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 P values*
n 899 900 899 900 899
Magnesium intake
(mg/1,000 kcal) 99.9 (91.7–106.1) 121.0 (116.5–125.2) 140.1 (134.8–145.5) 162.1 (155.8–169.3) 201.5 (187.7–233.3) —
Age (years) 23.9  3.8 24.3  3.7 25.0  3.6 25.5  3.4 26.0  3.2 0.01
Female sex (%) 52.4 46.8 46.8 53.0 64.7 0.01
African American (%) 82.7 67.7 48.5 31.1 23.0 0.01
Education (years) 12.8  1.8 13.3  2.1 13.9  2.1 14.4  2.3 14.8  2.3 0.01
Current smoker (%) 36.4 33.0 28.1 27.2 24.7 0.01
Alcohol intake (g/day) 10.2  20.1 12.9  22.2 12.2  19.6 13.4  22.6 10.6  16.2 0.01
Physical activity score
(units) 354.0  293.5 407.7  305.2 421.4  289.5 435.7  289.3 474.8  288.5 0.01
Family history of
diabetes (%) 16.2 14.0 14.6 12.3 11.4 0.02
BMI (kg/m
2) 25.0  5.9 25.0  5.5 24.5  4.7 24.1  4.4 24.0  4.3 0.01
Waist circumference
(cm) 78.5  12.9 79.1  11.7 78.4  10.6 77.3  10.7 76.2  10.0 0.01
Glucose (mg/dl) 81.3  8.8 81.9  9.0 81.6  8.5 82.2  7.7 82.0  7.4 0.29
Insulin (U/ml) 12.8  6.9 12.5  6.5 11.2  4.9 10.6  4.7 10.5  4.8 0.01
Systolic blood pressure
(mmHg) 111.2  10.8 111.5  11.2 110.8  10.9 109.9  10.2 109.2  11.3 0.01
Diastolic blood
pressure (mmHg) 68.2  10.2 68.8  10.2 69.2  9.5 68.8  9.0 68.2  9.3 0.11
Total energy intake
(kcal) 3,264  1,650 3,170  1,571 2,943  1,363 2,652  1,189 2,374  1,127 0.01
Total saturated fat (g) 53.4  31.3 51.6  28.3 47.8  25.0 42.3  21.6 35.2  20.6 0.01
Crude ﬁber (g) 4.7  2.9 5.4  3.0 5.6  3.1 6.0  3.2 6.7  4.0 0.01
Whole grain
(times/week) 4.9  7.3 7.4  8.6 9.7  9.7 11.0  9.5 13.1  11.1 0.01
Magnesium
supplementation
(mg) 1.6  9.4 4.0  15.7 9.5  25.2 17.9  35.9 69.4  137.1 0.01
Data are median (interquartile range), means  SD, or %. *P values are for any difference across the quintiles of magnesium intake using ANOVA, Kruskal-Wallis
test, or 
2 test as appropriate.
Magnesium intake and incidence of diabetes
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ings from the primary analysis (data not
shown).
In addition, we examined a few food
groups that are rich in magnesium. These
associations were qualitatively consistent
with magnesium intake. For example, the
multivariable-adjusted HRs of incident
diabetes were 1.00, 1.26 (95% CI 0.93–
1.71), 0.82 (0.57–1.17), 0.71 (0.48–
1.04), and 0.81 (0.55–1.20) (Ptrend 
0.03) across quintiles of whole grain
consumption.
By stratifying data according to sex,
ethnicity, family history of diabetes, and
BMI, respectively, the observed inverse
associations were more pronounced in
women, overweight individuals, and
thosewithoutafamilyhistoryofdiabetes.
However, none of the tests for interac-
tions among these variables showed sta-
tistical signiﬁcance (Fig. 1).
Magnesium intake was also inversely
associated with hs-CRP, IL-6, and ﬁbrin-
ogen levels after adjustment for potential
confounders. Moreover, a signiﬁcant in-
verse association between magnesium in-
take and HOMA-IR was observed (Table
3). Furthermore, although the Spearman
correlation coefﬁcient between serum
and total magnesium intake at year 20
was 0.07, serum magnesium levels were
signiﬁcantly inversely correlated with hs-
CRP and HOMA-IR (supplementary Table,
available in an online appendix at http://
care.diabetesjournals.org/cgi/content/full/
dc10-0994/DC1).
CONCLUSIONS— In this longitudi-
nal study, we found a signiﬁcant inverse
association between magnesium intake
and incidence of diabetes in young Amer-
ican adults. Our ﬁndings are generally
consistent with results from some previ-
ous studies (1,4–6). Conversely, three
other studies found no signiﬁcant associ-
ations between magnesium intake and
risk of diabetes (7–9), although one of
these reported that a low serum magne-
sium level was a strong, independent pre-
dictor of incident type 2 diabetes (7). Of
note, in a meta-analysis of cohort studies
(3), the pooled relative risk of type 2
diabetes per 100 mg/day increment of
magnesium intake was 0.85 (95% CI
0.79–0.92).
We observed an inverse association
between magnesium intake and HOMA-
IR. This ﬁnding indicates that the beneﬁ-
cialeffectsofmagnesiumintakeonriskof
diabetes may be partially due to role of
magnesiuminimprovinginsulinsensitiv-
ity (2,8,22) and suggests that low magne-
sium intake and insulin resistance may
detrimentally inﬂuence each other. Mag-
nesium is important as a second mes-
senger for insulin action. A reduced
intracellular magnesium concentration
may result in defective tyrosine kinase ac-
tivity during insulin signaling and de-
creased insulin sensitivity (12,13).
Moreover, insulin itself is an important
regulatory factor for intracellular magne-
sium accumulation (12).
An inverse association between
magnesiumintakeandhs-CRPlevelwas
reportedinthreecross-sectionalstudies
(10,11,23). In addition, an inverse as-
sociation between magnesium intake
andIL-6levelwasfoundinone(23)but
notinanotherstudy(11).Inthepresent
study, magnesium intake was inversely
associated with levels of hs-CRP, IL-6,
and ﬁbrinogen, and serum magnesium
Table 2—Incident diabetes according to total magnesium intake quintiles
Quintiles of total magnesium intake
Ptrend* 1 (lowest) 2 3 4 5 (highest)
Total cohort (n  4,497)
Magnesium intake
(mg/1,000 kcal) 99.9 (91.7–106.1) 121.0 (116.5–125.2) 140.1 (134.8–145.5) 162.1 (155.8–169.3) 201.5 (187.7–233.3) —
No. of
events/participants 81/899 85/900 77/899 52/900 35/899 —
Model 1 1.00 0.95 (0.70–1.30) 0.91 (0.66–1.26) 0.63 (0.43–0.92) 0.46 (0.30–0.71) 0.01
Model 2 1.00 0.89 (0.65–1.22) 0.88 (0.63–1.24) 0.72 (0.49–1.05) 0.52 (0.33–0.82) 0.01
Model 3 1.00 0.96 (0.70–1.32) 0.97 (0.68–1.38) 0.77 (0.51–1.18) 0.53 (0.32–0.86) 0.01
Supplement users
(n  1,205)
Magnesium intake
(mg/1,000 kcal) 123.6 (112.6–133.0) 151.0 (146.1–156.0) 172.6 (166.6–179.0) 196.0 (188.9–203.7) 248.8 (233.3–290.4)
No. of
events/participants 32/241 16/241 17/241 6/241 6/241
Model 3 1.00 0.66 (0.33–1.30) 0.70 (0.34–1.44) 0.24 (0.09–0.67) 0.32 (0.10–0.96) 0.01
Supplement nonusers
(n  3,292)
Magnesium intake
(mg/1,000 kcal) 97.0 (89.4–102.0) 115.1 (111.0–119.0) 130.1 (126.5–134.2) 149.7 (144.2–154.5) 180.0 (169.3–196.6)
No. of
events/participants 59/658 58/659 54/658 45/659 37/658
Model 3 1.00 0.96 (0.66–1.41) 0.79 (0.53–1.18) 0.79 (0.50–1.26) 0.74 (0.44–1.26) 0.21
Data are medians (interquartile range) for magnesium intake and HRs (95% CI) for models. *All models were constructed by the Cox proportional hazards
model. The median magnesium level in each quintile was created for the trend tests. Model 1: adjustment for age (continuous), sex, ethnicity (African
American or Caucasian), and study center; model 2: model 1 with additional adjustment for education (continuous), smoking status (never, former,
or current), alcohol consumption (none, 0.1–9.9, 10–19.9, or 20 g/day), physical activity (quintiles), family history of diabetes, BMI (25, 25–29.9, or
30 kg/m
2), systolic blood pressure (continuous), and total energy intake (quintiles); model 3: model 2 with additional adjustment for dietary intakes
(quintiles) of saturated fat and crude ﬁber.
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levels. These ﬁndings support another
possible pathway for altering systemic
inﬂammation and may explain, at least
in part, the potential beneﬁcial effect of
magnesium intake on diabetes risk.
The strengths of our study include a
long-term follow-up period, a large sam-
plesizeofyoungadults,andasamplewell
balanced for sex and ethnicity. Most pre-
viousﬁndingsarefromstudiesinmiddle-
aged or elderly individuals, who were
likely to have already had disease onset
and may have made lifestyle changes for
disease prevention or treatment. Further-
more,welongitudinallymeasuredseveral
inﬂammatory markers and fasting insu-
lin level (HOMA-IR), which enabled us
to explore potential pathophysiological
mechanisms for the beneﬁcial effects
of magnesium intake on diabetes risk.
Moreover, we deﬁned diabetes based
mainly on fasting and postprandial glu-
cose levels from an OGTT and A1C
measurements, in addition to a self-
reportedquestionnaire.Inpreviousstud-
ies (4–6,8,9), except the Atherosclerosis
Risk in Communities (ARIC) study (7),
all diabetes cases were self-reported. Our
study was further strengthened by our con-
sistent ﬁndings across dietary magnesium
intake, serum magnesium level, and con-
sumptionofwholegrains,amajorsourceof
magnesium.
Our study also had limitations. First,
the possibility of confounding from un-
known or unmeasured factors cannot be
completely ruled out. Participants in the
highest quintile of magnesium intake in
particularweremostlikelytotakesupple-
ments, meaning that these participants
may be more health-conscious and there-
fore different from participants in other
groups. However, our results are unlikely
to be substantially biased, given our ex-
tensive data analysis, consistent ﬁndings
in sensitivity analysis (e.g., stratiﬁed anal-
ysis based on supplementation) and sup-
portive biological mechanisms. Second,
there is an inherent limitation in dietary
assessmentofindividualnutrientsinclud-
ing magnesium. Thus, observed associa-
tions are likely to reﬂect consumption of
foods rich in magnesium such as whole
grains, nuts, legumes, fruits, and vegeta-
bles but may not be the result of an iso-
lated effect of magnesium intake. Third,
although the inverse association of mag-
nesium intake with inﬂammatory mark-
ers remained after further adjustment for
some health conditions including asthma
and serum cholesterol levels, we could
notfullycontrolforallpossiblesourcesof
systemic inﬂammation (e.g., acute infec-
tion) because of lack of information.
Fourth, lack of fasting glucose data for
years 2 and 5 may have resulted in un-
derestimation and misclassiﬁcation of
diabetes at these times. However, this
limitation should not substantially bias
our results, because diabetes incidence
was relatively low for these years, when
most participants were in their 20s, and
many cases of diabetes diagnosed be-
tween years 0 and 7 would have been
detected at year 7.
A recent clinical trial suggested that
magnesium supplementation improves
insulin sensitivity in hypomagnesemic
nondiabetic participants (24). In a
crossover trial among healthy individu-
als, magnesium supplementation inhib-
ited fat absorption and decreased
postprandial triglyceride levels (25). In
our data, total magnesium intake was
important regardless of its source.
Therefore, increasing magnesium in-
take may be important for improving
insulin sensitivity, reducing systemic
inﬂammation, and decreasing diabetes
risk.
In summary, magnesium intake was
inversely associated with incidence of
diabetes.Thepotentialbeneﬁcialeffects
of magnesium intake on the risk of dia-
betes may be explained by the favorable
effects of magnesium on systemic in-
ﬂammation and insulin resistance. Fur-
therlarge-scaleclinicaltrialsareneeded
to establish causal inference and eluci-
datethemechanismsbehindthispoten-
tial beneﬁt.
Figure 1—HRs (95% CI) for incident diabetes in participants in the highest magnesium intake quintile compared with those in the lowest quintile,
stratiﬁed by sex, ethnicity, family history of diabetes, and BMI. Data in the parentheses in the group column are the ratio of the number of events to
numberofparticipants.Theadjustedcovariatesinthemodelswerethesameasthoseformodel3inTable2.*Continuousvariablesusingthemedian
value in each quintile were created for trend tests. A.A., African American; FH, family history.
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